Loading provider…
Loading provider…
Nephrology Physician in Cherry Hill, NJ
NPI: 1003042490Primary Practice Location
Renal Center of Sewell
401 Kings S Hwy, Cherry Hill, NJ
Primary Employer
Banerjee Kidney Center
banerjeekidneycenter.com
HQ Phone
Get M.D. Trina's Phone NumberMobile
Get M.D. Trina's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
NJ State Medical License
2011 - 2027
PA State Medical License
2005 - 2024
NY State Medical License
2009 - 2012

American Board of Internal Medicine
Nephrology
Drexel University College Of Medicine
drexel.edu
Medical School
Until 2005
NYU Grossman School of Medicine
med.nyu.edu
Fellowship • Nephrology
2009 - 2011
Drexel University College of Medicine/Hahnemann University Hospital
Residency • Internal Medicine
2005 - 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 268 | 1,814 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 257 | 566 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 231 | 317 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 88 | 95 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 72 | 237 |
Use of finerenone in patients with chronic kidney disease at high risk of heart failure.
Authors: Francisco Ramirez-Valle, Sachin Jhawar, Prabhjot Singh, Hania Kassem, Jerome Lowenstein
Journal: PLoS One
Publication Date: 2015-03-26
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DIAGNOSTIC_TEST: DetermaRX
Lead Sponsor: Ain Shams University
Intervention / Treatment: DIAGNOSTIC_TEST: ultrasound detection of body composition
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Matching Placebo, DRUG: OCA